台灣樂天醫藥生技股份有限公司

Company Introduction

暫不提供
台北市中正區忠孝西路
Contact Person
People Operations
Phone
暫不提供
Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox™ technology platform, which utilizes antibodies conjugated with payloads that are specifically activated at the tumor site. Our first clinical product received marketing approval in Japan from the Ministry of Health, Labour and Welfare for ASP-1929 PIT to treat unresectable locally advanced or recurrent head and neck cancer - and is also in Phase III pivotal clinical testing globally to treat terminal cancer patients. This is a first-in-class product with unique pharmacological activity and with the potential to have a broad impact in cancer. Rakuten Medical is committed to its mission to conquer cancer and aims to realize a society where cancer patients can lead fulfilling lives. Headquartered in the United States, Rakuten Medical has 5 locations in 5 countries: the United States, Japan, Taiwan, Switzerland and India. For more information, visit www.rakuten-med.com.

Industry Sector
其他專業/科學及技術業
Related Links
Others

Main Products

The Alluminox™ platform is an investigational platform based on a cancer therapy called photoimmunotherapy, which was developed by Dr. Hisataka Kobayashi and team from the National Cancer Institute in the United States. Rakuten Medical is developing the Alluminox platform as a technology consisting of a drug, device, and other related components. The drug component of the platform consists of a targeting moiety conjugated with one or more dyes leading to selective cell surface binding. The device component consists of a light source that locally illuminates the targeted cells with non-thermal light to transiently activate the drug. Pre-clinical data have shown that this activation elicits rapid and selective necrosis of targeted cells through a biophysical process that compromises the membrane integrity of the targeted cells. Therapies developed on Alluminox may also result in local and systemic innate and adaptive immune activation due to immunogenic cell death of the targeted cells and/or the removal of immunosuppressive elements within the microenvironment. Outside of Japan, Alluminox therapies have not yet been approved as safe or effective by any regulatory authority.

Benefits

We are proud to offer a competitive compensation plan with comprehensive benefits package. - 15 days annual leave starts from the first year of employment - Full paid sick leave - Annual health examination program

Jobs

In-house CRA 台灣樂天醫藥生技股份有限公司
Salary negotiable
台北市中正區
1年以上
Key Duties and Responsibilities • Manage clinical studies by planning and assisting in study start-up activities such as the creation of Monitoring Plan, Laboratory Manual, Pharmacy Manual, Site Initiation Presentations, CRF Completion Guidelines and various forms and study tracking and management documents. • Assist with oversight and management of CRO, including project tracking of subject and site information. • Assist with the development of site tools and clinical trial start up activities. • Establish and maintain the documents within electronic and/or paper Trial Master File with minimal supervision. • Receive and review all regulatory documents from sites for accuracy and compliance to company SOPs and federal guidelines, tracks all information for reference, and maintains documentation as required. • Review site study documents (e.g., informed consent template and study tools/worksheets). • Assist and/or contribute to the creation and maintenance of study materials for clinical studies, including but not limited to site and CRA training material, regulatory document templates, study binders, study plans, study communications and presentations. • Assist clinical operation leads in the development, handling, distribution, filing and archiving of essential documents in the TMF. • Handle incoming and outgoing clinical trial related materials shipments to site, study team, CRAs and vendors, as needed. • Provide assistance in confirming and verifying vendor or site contracts, as well as reviewing associated invoice expenditures for accuracy and compliance. • Assist with all aspects of initial study drug/device shipment release including regulatory packet review and study-drug release. • Assist clinical study team with the planning, preparation, and on-site support of investigators’ meetings. • Perform or oversee CRO pre-site selection and site initiation, as well as interim, close-out, and co-monitoring visits to ensure compliance with protocol and regulatory requirements, to assure good site performance, and evaluate CRO CRA performance. • Communicate directly with sites, Contract Research Organizations (CROs) and CRAs to obtain updated information, essential documents, etc. to assist with driving start-up, study conduct, and/or close out activities. • Review and manage monitoring report review and follow-up within project-specific timelines. • Assist with tracking of clinical trial progress including status update reports, as requested. • Comply with company regulatory, safety and compliance procedures and practices.
Full-time
Mid to Senior Level
English Required
Partially Remote
10/14 Updated